ARCHIVES

Adding Topotecan To Standard Treatment Doesn’t Improve Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 33 No. 10 | October 29, 2010

Download PDF Visit The Full Archive

Related Articles

Prevention Clinical Trials Heads Greenwalk Priority Lists For ‘86

February 8, 1985

CAM Therapies Should Be Held to Conventional Standards and Congress Should Toughen Dietary Supplements Act, IOM Panel Says.

January 21, 2005

CCI Gets Qualified Approval To Continue

January 18, 1980

In Brief: Robert Bast Succeeds Singleton As Director Of Duke Cancer Center; Robert Bell Deputy

August 14, 1987

ACCC Annual Meeting To Study Organizing Community Care

January 26, 1979

Two Doses of the Vaccine Cervarix Can Be As Effective As Three

September 30, 2011